> top > projects > Inflammaging > docs > PubMed:31147635 > annotations
Inflammaging  

PubMed:31147635 JSONTXT 2 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T1 0-57 Sentence denotes Therapeutic developments for Duchenne muscular dystrophy.
T1 0-57 Sentence denotes Therapeutic developments for Duchenne muscular dystrophy.
T2 58-147 Sentence denotes Duchenne muscular dystrophy (DMD) is caused by the lack of functional dystrophin protein.
T2 58-147 Sentence denotes Duchenne muscular dystrophy (DMD) is caused by the lack of functional dystrophin protein.
T3 148-355 Sentence denotes Improvements in patient care and disease management have slowed down disease progression, but current treatments cannot stop the relentless loss of muscle tissue and function, which leads to premature death.
T3 148-355 Sentence denotes Improvements in patient care and disease management have slowed down disease progression, but current treatments cannot stop the relentless loss of muscle tissue and function, which leads to premature death.
T4 356-415 Sentence denotes Research is ongoing to develop effective therapies for DMD.
T4 356-415 Sentence denotes Research is ongoing to develop effective therapies for DMD.
T5 416-707 Sentence denotes Gene-addition, exon-skipping, stop codon readthrough and genome-editing therapies can restore the expression of partially functional dystrophin protein, whereas other therapeutic approaches aim to improve muscle function and quality by targeting pathways involved in the pathogenesis of DMD.
T5 416-707 Sentence denotes Gene-addition, exon-skipping, stop codon readthrough and genome-editing therapies can restore the expression of partially functional dystrophin protein, whereas other therapeutic approaches aim to improve muscle function and quality by targeting pathways involved in the pathogenesis of DMD.
T6 708-885 Sentence denotes This Review outlines important developments in these research areas and specifically focuses on new therapies that are in the clinical trial phase or have already been approved.
T6 708-885 Sentence denotes This Review outlines important developments in these research areas and specifically focuses on new therapies that are in the clinical trial phase or have already been approved.